Associate Professor
University of Torino
Torino, Piemonte, Italy
• Dr Larocca is associate professor of Hematology at the University of Turin, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Turin, Italy. She studied Medicine at the University of Milan (1996-2001) and completed her residency in Hematology at the same institution (2001-2005). In 2014, she obtained her PhD in Pathology and Experimental Oncology at the University of Turin
• Dr Larocca is involved in the design, development, and coordination of phase I/II/III clinical trials for the treatment of multiple myeloma in tight collaboration with the European Myeloma Network (EMN, EMN Italy Foundation) and the Gruppo Italiano Malattie EMatologiche dell’Adulto (GIMEMA). She is currently the local principal investigator in several multicenter clinical trials
• Dr Larocca’s main research focuses on the diagnosis and the clinical and experimental treatment of patients with multiple myeloma and associated disorders, particularly of elderly and frail patients. Her interests also include the use of new biological molecules, monoclonal antibodies, immunotherapeutic agents, CAR-T cells, and stem-cell transplantation techniques. She is a member of EMN, EHA, and ASH. She is author and coauthor of several papers published in peer-reviewed journals
Increasing heterogeneity of the aging MM patient population: diagnostic challenges
Friday, September 29, 2023
11:45 AM – 11:55 AM EEST